United States
Germany
Japan
United Kingdom
China
ANGPTL2 (NM_012098) Human Tagged ORF Clone Lentiviral Particle
CAT＃: RC201917L1V
- LentiORF®
-
Lenti ORF particles, ANGPTL2 (Myc-DDK-tagged)-Human angiopoietin-like 2 (ANGPTL2), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 8,930.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
| Product Data | |
| Product Name | ANGPTL2 (NM_012098) Human Tagged ORF Clone Lentiviral Particle |
| Synonyms | ARP2; HARP |
| Vector | pLenti-C-Myc-DDK |
| ACCN | NM_012098 |
| ORF Size | 1479 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(RC201917).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_012098.2 |
| RefSeq Size | 3572 bp |
| RefSeq ORF | 1482 bp |
| Locus ID | 23452 |
| Domains | FBG |
| Protein Families | Druggable Genome, ES Cell Differentiation/IPS, Secreted Protein |
| MW | 57.1 kDa |
| Gene Summary | Angiopoietins are members of the vascular endothelial growth factor family and the only known growth factors largely specific for vascular endothelium. Angiopoietin-1, angiopoietin-2, and angiopoietin-4 participate in the formation of blood vessels. ANGPTL2 protein is a secreted glycoprotein with homology to the angiopoietins and may exert a function on endothelial cells through autocrine or paracrine action. [provided by RefSeq, Jul 2008] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
其它ANGPTL2产品
Customer
Reviews
Loading...
